Clariant today announced the successful placement of EUR 500 million in unsecured Eurobonds issued by its subsidiary Clariant International Financial Services (Luxembourg) S.à.r.l. and guaranteed by Clariant AG.
Clariant has received U.S. Food and Drug Administration (FDA) approval for its bio-based Licocare RBW wax additives for use in rigid polyvinyl chloride (PVC) food-contact applications. The authorization, effective May 7, 2026, extends the company's existing FDA approval beyond polyester materials to include rigid PVC.